臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pei jer chen"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 511-560 of 883 (18 Page(s) Totally)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-07-03T03:34:13Z	SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma model	Tai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:34:13Z	Eltrombopag increases platelet numbers in thrombocytopenic patients with hcv infection and cirrhosis, allowing for effective antiviral therapy	Afdhal N.H.; Dusheiko G.M.; Giannini E.G.; PEI-JER CHEN; Han K.-H.; Mohsin A.; Rodriguez-Torres M.; Rugina S.; Bakulin I.; Lawitz E.; Shiffman M.L.; Tayyab G.-U.-N.; Poordad F.; Kamel Y.M.; Brainsky A.; Geib J.; Vasey S.Y.; Patwardhan R.; Campbell F.M.; Theodore D.
臺大學術典藏	2021-07-03T03:34:12Z	Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection	Liu C.-J.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:12Z	Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma	Tai W.-T.; Shiau C.-W.; PEI-JER CHEN; Chu P.-Y.; Huang H.-P.; Liu C.-Y.; Huang J.-W.; Chen K.-F.
臺大學術典藏	2021-07-03T03:34:12Z	Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality	Liu C.-J.; Chu Y.-T.; Shau W.-Y.; Kuo R.N.; PEI-JER CHEN; Lai M.-S.
臺大學術典藏	2021-07-03T03:34:11Z	Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:11Z	Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin	Chen M.-Y.; Liu C.-H.; Chen T.-C.; Su T.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-07-03T03:34:11Z	Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy	Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:10Z	Reply	Hsu C.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:10Z	Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously	Cheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; Su T.-H.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-07-03T03:34:10Z	Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study	Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏	2021-07-03T03:34:09Z	Anti-viral treatment and cancer control	Shih W.-L.; Fang C.-T.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:09Z	Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy	Huang Y.-W.; Hsu C.-K.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Liang C.-W.; Chen D.-S.; PEI-JER CHEN; Hsu P.-N.; Yang S.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:09Z	Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan	Chen C.-L.; Yang W.-S.; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; Liu C.-J.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.; Chen C.-J.
臺大學術典藏	2021-07-03T03:34:09Z	Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications	Wu H.-L.; Kao J.-H.; Chen T.-C.; Wu W.-H.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen D.-S.; PEI-JER CHEN; Liu C.-J.
臺大學術典藏	2021-07-03T03:34:08Z	Erratum: Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia (Journal of Hepatology (2013) 59 (1073-1080))	Chen D.-S.; Locarnini S.; Wait S.; Bae S.-H.; PEI-JER CHEN; Fung J.Y.Y.; Kim H.S.; Lu S.-N.; Sung J.; Tanaka J.; Wakita T.; Ward J.; Wallace J.
臺大學術典藏	2021-07-03T03:34:08Z	A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: A prospective study with propensity score matching analysis	Huang T.-S.; Huang S.-S.; Shyu Y.-C.; Lee C.-H.; Jwo S.-C.; PEI-JER CHEN; Chen H.-Y.
臺大學術典藏	2021-07-03T03:34:08Z	Hepatitis B virus: Pathogenesis and host immune response	Yang H.-C.; Yeh S.-H.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:07Z	The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo	Lin S.-R.; Yang H.-C.; Kuo Y.-T.; Liu C.-J.; Yang T.-Y.; Sung K.-C.; Lin Y.-Y.; Wang H.-Y.; Wang C.-C.; Shen Y.-C.; Wu F.-Y.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:07Z	Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model	Tzeng H.-T.; Tsai H.-F.; Chyuan I.-T.; Liao H.-J.; Chen C.-J.; PEI-JER CHEN; Hsu P.-N.
臺大學術典藏	2021-07-03T03:34:07Z	Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: A nationwide cohort study	Yeh Y.-C.; Liu C.-J.; Kuo R.N.; Lai C.-L.; Shau W.-Y.; PEI-JER CHEN; Lai M.-S.
臺大學術典藏	2021-07-03T03:34:06Z	Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription	Wu C.-H.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏	2021-07-03T03:34:06Z	Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma	Liu J.; Yang H.-I.; Lee M.-H.; Lu S.-N.; Jen C.-L.; Batrla-Utermann R.; Wang L.-Y.; You S.-L.; Hsiao C.K.; PEI-JER CHEN; Chen C.-J.
臺大學術典藏	2021-07-03T03:34:06Z	The driving circuit of HBx and androgen receptor in HBV-related hepatocarcinogenesis	Wang S.-H.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:06Z	Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence	Liu C.-J.; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:34:05Z	Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870	Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN; Lee S.-D.; Yu M.-W.
臺大學術典藏	2021-07-03T03:34:05Z	Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection	Colvin R.A.; Tanwandee T.; Piratvisuth T.; Thongsawat S.; Hui A.J.; Zhang H.; Ren H.; PEI-JER CHEN; Chuang W.-L.; Sobhonslidsuk A.; Li R.; Qi Y.; Praestgaard J.; Han Y.; Xu J.; Stein D.S.; Chien R.-N.; Flisiak R.; Jablkowski M.; Liaw Y.-F.; Sung J.J.-Y.
臺大學術典藏	2021-07-03T03:34:05Z	A Lego?-like swappable fluidic module for bio-chem applications	Hsieh Y.-F.; Yang A.-S.; Chen J.-W.; Liao S.-K.; Su T.-W.; Yeh S.-H.; PEI-JER CHEN; Chen P.-H.
臺大學術典藏	2021-07-03T03:34:04Z	Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection	Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-07-03T03:34:04Z	Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages	Liu C.-J.; Chen T.-C.; PEI-JER CHEN; Wang H.-Y.; Tseng T.-C.; Cheng H.-R.; Liu C.-H.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:04Z	New insights into the evolutionary rate of hepatitis B virus at different biological scales	Lin Y.-Y.; Liu C.; Chien W.-H.; Wu L.-L.; Tao Y.; Wu D.; Lu X.; Hsieh C.-H.; PEI-JER CHEN; Wang H.-Y.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:04Z	Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan	Chen C.-L.; Yang J.-Y.; Lin S.-F.; Sun C.-A.; Bai C.-H.; You S.-L.; Chen C.-J.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:03Z	Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota	Chou H.-H.; Chien W.-H.; Wu L.-L.; Cheng C.-H.; Chung C.-H.; Horng J.-H.; Ni Y.-H.; Tseng H.-T.; Wu D.; Lu X.; Wang H.-Y.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:03Z	Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma	Li C.-L.; Yeh K.-H.; Liu W.-H.; Chen C.-L.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏	2021-07-03T03:34:03Z	Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection	Song L.-W.; Liu P.-G.; Liu C.-J.; Zhang T.-Y.; Cheng X.-D.; Wu H.-L.; Yang H.-C.; Hao X.-K.; Yuan Q.; Zhang J.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN; Xia N.-S.
臺大學術典藏	2021-07-03T03:34:02Z	Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy	Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; Su T.-H.; Yang H.-C.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:02Z	Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection	Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:02Z	Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping	Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:01Z	Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping	Song L.-W.; Wang Y.-B.; Fang L.-L.; Wu Y.; Yang L.; Chen J.-Y.; Ge S.-X.; Zhang J.; Xiong Y.-Z.; Deng X.-M.; Min X.-P.; Zhang J.; PEI-JER CHEN; Yuan Q.; Xia N.-S.
臺大學術典藏	2021-07-03T03:34:01Z	Predicting hepatitis B virus (HBV) surface antigen seroclearance in HBV e antigen-negative patients with chronic hepatitis B: External validation of a scoring system	Liu J.; Tseng T.-C.; Yang H.-I.; Lee M.-H.; Batrla-Utermann R.; Jen C.-L.; Lu S.-N.; Wang L.-Y.; You S.-L.; PEI-JER CHEN; Chen C.-J.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:01Z	Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model	Chyuan I.-T.; Tsai H.-F.; Tzeng H.-T.; Sung C.-C.; Wu C.-S.; PEI-JER CHEN; Hsu P.-N.
臺大學術典藏	2021-07-03T03:34:00Z	Contribution of adiponectin and its type 1 receptor to age-related hearing impairment	Wu C.-C.; Tsai C.-H.; Lu Y.-C.; Lin H.-C.; Hwang J.-H.; Lin Y.-H.; Yang W.-S.; PEI-JER CHEN; Liao W.-C.; Lee Y.L.; Liu T.-C.; Hsu C.-J.
臺大學術典藏	2021-07-03T03:34:00Z	Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity	Huang M.-T.; Liu W.-L.; Lu C.-W.; Huang J.-J.; Chuang H.-L.; Huang Y.-T.; Horng J.-H.; Liu P.; Han D.-S.; Chiang B.-L.; Shih C.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:00Z	Development of risk scoring system for stratifying population for hepatocellular carcinoma screening	Hung Y.-C.; Lin C.-L.; Liu C.-J.; Hung H.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Chuang S.-C.; Yu M.-W.
臺大學術典藏	2021-07-03T03:33:59Z	Gender disparity in chronic hepatitis B: Mechanisms of sex hormones	Wang S.-H.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏	2021-07-03T03:33:59Z	Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏	2021-07-03T03:33:59Z	Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition	Su T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; PEI-JER CHEN; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-07-03T03:33:58Z	Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study	Park J.-W.; Chen M.; Colombo M.; Roberts L.R.; Schwartz M.; PEI-JER CHEN; Kudo M.; Johnson P.; Wagner S.; Orsini L.S.; Sherman M.
臺大學術典藏	2021-07-03T03:33:58Z	Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers	Tseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:58Z	Treatment of liver cancer	Liu C.-Y.; Chen K.-F.; PEI-JER CHEN

Showing items 511-560 of 883 (18 Page(s) Totally)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 51805728 ???header.onlineuser??? : 1047 ???header.sponsordeclaration???